Prevascularization of porous biodegradable polymers

Highly porous biocompatible and biodegradable polymers in the form of cylindrical disks of 13.5 mm diameter were implanted in the mesentery of male syngeneic Fischer rats for a period of 35 days to study the dynamics of tissue ingrowth and the extent of tissue vascularity, and to explore their potential use as substrates for cell transplantation. The advancing fibrovascular tissue was characterized from histological sections of harvested devices by image analysis techniques. The rate of tissue ingrowth increased as the porosity and/or the pore size of the implanted devices increased. The time required for the tissue to fill the device depended on the polymer crystallinity and was smaller for amorphous polymers. The vascularity of the advancing tissue was consistent with time and independent of the biomaterial composition and morphology. Poly(L‐lactic acid) (PLLA) devices of 5 mm thickness, 24.5% crystallinity, 83% porosity, and 166 μm median pore diameter were filled by tissue after 25 days. However, the void volume of prevascularized devices (4%) was minimal and not practical for cell transplantation. In contrast, for amporphous PLLA devices of the same dimensions, and the similar porosity of 87% and median pore diameter of 179 μm, the tissue did not fill completely prevascularized devices, and an appreciable percentage (21%) of device volume was still available for cell engraftment after 25 days of implantation. These studies demonstrate the feasibility of creating vascularized templates of amorphous biodegradable polymers for the transplantation of isolated or encapsulated cell populations to regenerate metabolic organs and tissues. © 1993 John Wiley & Sons, Inc.

[1]  R. Langer,et al.  Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. , 1994, Biomaterials.

[2]  C. Colton,et al.  Bioengineering in development of the hybrid artificial pancreas. , 1991, Journal of biomechanical engineering.

[3]  J. Vacanti,et al.  Beyond transplantation. Third annual Samuel Jason Mixter lecture. , 1988, Archives of surgery.

[4]  A. Gristina,et al.  Biomaterial-centered infection: microbial adhesion versus tissue integration. , 1987, Science.

[5]  R Langer,et al.  Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. , 1993, Journal of biomedical materials research.

[6]  R Langer,et al.  Cell seeding in porous transplantation devices. , 1993, Biomaterials.

[7]  P. Libby,et al.  Implantation of vascular grafts lined with genetically modified endothelial cells. , 1989, Science.

[8]  J. Leiden,et al.  Systemic delivery of recombinant proteins by genetically modified myoblasts. , 1991, Science.

[9]  R Langer,et al.  Laminated three-dimensional biodegradable foams for use in tissue engineering. , 1993, Biomaterials.

[10]  Yoshito Ikada,et al.  Thermal characterization of polylactides , 1988 .

[11]  E. Nabel,et al.  Recombinant gene expression in vivo within endothelial cells of the arterial wall. , 1989, Science.

[12]  D E Ingber,et al.  Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. , 1993, Journal of biomedical materials research.

[13]  R Langer,et al.  Tissue engineering by cell transplantation using degradable polymer substrates. , 1991, Journal of biomechanical engineering.

[14]  R. Linhardt,et al.  Degradation of poly(ester) microspheres. , 1990, Biomaterials.

[15]  H. Blau,et al.  Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. , 1991, Science.

[16]  D E Ingber,et al.  Hepatocyte culture on biodegradable polymeric substrates , 1991, Biotechnology and bioengineering.

[17]  R Langer,et al.  Selective cell transplantation using bioabsorbable artificial polymers as matrices. , 1988, Journal of pediatric surgery.